| Entry |
|
|---|
| Name |
Peginesatide (USAN/INN) |
|---|
| Formula |
C231H350N62O58S6(C2H4O)a(C2H4O)b
|
|---|
| Structure |
 |
|---|
| Remark |
|
|---|
| Efficacy |
Anti-anemic, Erythropoietin receptor agonist |
|---|
| Type |
Modified peptide |
|---|
| Comment |
a functional analog of erythropoietin [HSA: 2056] [KO: K05437]
Treatment of anemia associated with chronic kidney disease
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B03 ANTIANEMIC PREPARATIONS
B03X OTHER ANTIANEMIC PREPARATIONS
B03XA Other antianemic preparations
B03XA04 Peginesatide
D09946 Peginesatide (USAN/INN)
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
EPOR
D09946 Peginesatide (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
